ONCAlert | Upfront Therapy for mRCC
Bladder Cancer: Articles
FDA Updates Frontline Pembrolizumab, Atezolizumab Urothelial Carcinoma Labels to Include PD-L1 Status
2:08 PM, Thu June 21, 2018
Responses Found in Advanced Urothelial Carcinoma With FGFR Inhibitor
2:15 PM, Mon June 4, 2018
Future Directions of Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer
6:04 PM, Fri April 20, 2018
Phase III POUT Data Supports Adjuvant Chemotherapy as Standard for Patients With UTUC
3:57 PM, Thu April 12, 2018
Expert Discusses Immunotherapy Advancements in a Rapidly Changing GU Field
4:09 PM, Mon April 2, 2018
Erdafitinib Granted Breakthrough Therapy Designation by FDA for Urothelial Carcinoma
7:52 PM, Thu March 15, 2018
Targeted Therapies in Oncology Welcomes Arjun Balar as Editor-In-Chief
7:42 PM, Thu March 15, 2018
FDA Approves Expanded Indication for Blue Light Cytoscopy With Cysview for Bladder Cancer Detection
3:17 PM, Thu March 8, 2018
